— Organigram Holdings Inc. (NASDAQ: OGI) reported a net loss from continuing operations of $9 million for the first quarter of 2020, vs. a profit of $29.5 million last year.
— Loss per share was $0.006, compared to earnings per share of $0.195 per share in the year-ago period
— First-quarter net revenues more than doubled to $25.15 million from $12.44 million last year
— Gross margin, before fair value changes to biological assets and inventories, rose to $9.3 million from $8.8 million a year earlier
— Adjusted EBITDA was $4.9 million during the three-month period, compared to $6.8 million in the first quarter of 2019
— Expects to start shipping Edison + Feather ready-to-go distillate pens before the end of January 2020
— Plans to launch cannabis-infused dissolvable powder product in the second quarter of calendar 2020
Most Popular
AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates
Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings. The company reported worldwide net revenues of $13.3 billion for the
Colgate-Palmolive (CL) Q1 2025 Earnings: Key financials and quarterly highlights
Colgate-Palmolive Company (NYSE: CL) reported its first quarter 2025 earnings results today. Net sales decreased 3.1% year-over-year to $4.9 billion. Organic sales growth was 1.4%. Net income attributable to Colgate-Palmolive Company rose
Meta Platforms (META) set to report Q1 earnings. Here’s what to expect
After integrating artificial intelligence into its products, Meta Platforms, Inc. (NASDAQ: META) is investing heavily in the metaverse project. Yet, the tech giant has maintained healthy cash flows and consistently
Comments
Comments are closed.